Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.565
+0.045 (2.96%)
May 12, 2025, 4:00 PM - Market closed
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $15.92 million as of May 12, 2025. Its market cap has increased by 0.77% in one year.
Market Cap
15.92M
Enterprise Value
7.72M
1-Year Change
0.77%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $15.92M, a decrease of -86.19%. That is a compound annual growth rate of -24.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 15.50M | -24.76% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |